Two Sigma Securities’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,980
| Closed | -$208K | – | 764 |
|
|
2020
Q2 | $208K | Buy |
+2,980
| New | +$208K | ﹤0.01% | 394 |
|
|
2018
Q2 | – | Sell |
-5,090
| Closed | -$524K | – | 1306 |
|
|
2018
Q1 | $524K | Buy |
+5,090
| New | +$524K | ﹤0.01% | 435 |
|
|
2017
Q3 | – | Sell |
-3,498
| Closed | -$265K | – | 1044 |
|
|
2017
Q2 | $265K | Buy |
+3,498
| New | +$265K | 0.05% | 406 |
|
|
2016
Q3 | – | Sell |
-3,243
| Closed | -$241K | – | 734 |
|
|
2016
Q2 | $241K | Buy |
+3,243
| New | +$241K | 0.13% | 213 |
|